These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27172696)

  • 21. Pityriasis rubra pilaris: a clinical review.
    Pincus DJ
    Dermatol Nurs; 2005 Dec; 17(6):448-51. PubMed ID: 16463927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early presentation of pityriasis rubra pilaris.
    Caplan SE; Lowitt MH; Kao GF
    Cutis; 1997 Dec; 60(6):291-6. PubMed ID: 9426969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pityriasis rubra pilaris, type 1.
    Booth AV; Ma L
    Dermatol Online J; 2005 Dec; 11(4):9. PubMed ID: 16403381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The therapeutic possibilities in lichen ruber pilaris].
    Kalamkarian AA; Chistiakova IA
    Vestn Dermatol Venerol; 1990; (9):36-9. PubMed ID: 2284854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pityriasis rubra pilaris sensitive to narrow band-ultraviolet B light therapy.
    Vergilis-Kalner IJ; Mann DJ; Wasserman J; Petronic-Rosic V; Tsoukas MM
    J Drugs Dermatol; 2009 Mar; 8(3):270-3. PubMed ID: 19271375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab.
    Manoharan S; White S; Gumparthy K
    Australas J Dermatol; 2006 May; 47(2):124-9. PubMed ID: 16637810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acantholytic pityriasis rubra pilaris associated with topical use of imiquimod 5%: case report and literature review.
    Leite OG; Tagliolatto S; Souza EM; Cintra ML
    An Bras Dermatol; 2020; 95(1):63-66. PubMed ID: 31789270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral pityriasis rubra pilaris.
    Martinez Calixto LE; Suresh L; Matsumura E; Aguirre A; Radfar L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 May; 101(5):604-7. PubMed ID: 16632271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiologic, Clinicopathologic, Diagnostic, and Management Challenges of Pityriasis Rubra Pilaris: A Case Series of 100 Patients.
    Ross NA; Chung HJ; Li Q; Andrews JP; Keller MS; Uitto J
    JAMA Dermatol; 2016 Jun; 152(6):670-5. PubMed ID: 26963004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulsed dye laser as an adjunctive treatment for therapy-resistant pityriasis rubra pilaris.
    Lee J; Iyengar S; Zinn Z
    J Am Acad Dermatol; 2020 Dec; 83(6):e391-e392. PubMed ID: 32171814
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of pityriasis rubra pilaris with pimecrolimus cream 1%.
    Gregoriou S; Argyriou G; Christofidou E; Vranou A; Rigopoulos D
    J Drugs Dermatol; 2007 Mar; 6(3):340-2. PubMed ID: 17373199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy?
    Ivanova K; Itin P; Haeusermann P
    Dermatology; 2012; 224(2):120-5. PubMed ID: 22508269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of Wong's dermatomyositis.
    Caporali R; Cavagna L; Bellosta M; Bogliolo L; Montecucco C
    Clin Rheumatol; 2004 Feb; 23(1):63-5. PubMed ID: 14749988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pityriasis rubra pilaris: evolution of challenges in promising treatment options.
    Sehgal VN; Srivastava G; Verma P
    Skinmed; 2012; 10(1):18-23. PubMed ID: 22324172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular Psoriasis: Differentiation from Pityriasis Rubra Pilaris-An Illustrative Case and Review of the Literature.
    Nguyen CV; Farah RS; Maguiness SM; Miller DD
    Pediatr Dermatol; 2017 Jan; 34(1):e65-e68. PubMed ID: 27874201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pityriasis rubra pilaris: a rare inflammatory dermatosis.
    Kelly A; Lally A
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29440245
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.
    Di Stefani A; Galluzzo M; Talamonti M; Chiricozzi A; Costanzo A; Chimenti S
    J Dermatol Case Rep; 2013 Mar; 7(1):5-9. PubMed ID: 23580907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pityriasis Rubra Pilaris in a 3-Year-Old Male.
    Stacey SK; Novek SJ; Maddox CL
    Mil Med; 2016 Mar; 181(3):e298-301. PubMed ID: 26926758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythrodermic pityriasis rubra pilaris treatment: Two case reports and literature review.
    Camela E; Miano C; Di Caterino P; Lo Presti M; De Fata Salvatores G; Fabbrocini G; Megna M
    Dermatol Ther; 2020 Nov; 33(6):e14223. PubMed ID: 32820849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pityriasis rubra pilaris: a case series of 28 patients.
    Kromer C; Lippert U; Schön MP; Mössner R
    Eur J Dermatol; 2020 Oct; 30(5):569-579. PubMed ID: 33021474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.